Dahlia Biosciences

Venture Round
dahliabio.com Biotech & Healthcare San Francisco, United States
Total Funding Undisclosed
Latest Round Undisclosed Venture Round
Last Announced Undisclosed
Investors 3 Backers
Decision Makers 3 Verified

About Dahlia Biosciences

Dahlia Biosciences offers premium RNA Flow Assays designed for researchers and scientists in the life sciences industry. Discover our range of products and solutions today.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters San Francisco, United States
Tracked Since Oct 11, 2026

Web & Domain Identity

Official Website dahliabio.com
Domain Registered Date May 25, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    dahliabio.com

Investors & Backers

3
IndieBio
SOSV
SOSV SF & NY (Fka IndieBio)

Funding History

Venture Round · Undisclosed

Backers: IndieBio, SOSV, SOSV SF & NY (Fka IndieBio)

Undisclosed Source

Founders & Leadership

4

Brad Taft

Co-Founder & CSO

Work email & phone locked Unlock →

Michael Lin

Founder

Work email & phone locked Unlock →

Samuel Sternberg

Founder

Work email & phone locked Unlock →

Un Kwon

Co-Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts